×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NUVB – nuvation bio inc. class a (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NUVB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/16
06:32 pm
nuvb
Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib [Yahoo! Finance]
Low
Report
Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib [Yahoo! Finance]
1/16
11:26 am
nuvb
A Look At Nuvation Bio (NUVB) Valuation After The Eisai Taletrectinib Licensing Deal [Yahoo! Finance]
Low
Report
A Look At Nuvation Bio (NUVB) Valuation After The Eisai Taletrectinib Licensing Deal [Yahoo! Finance]
1/12
09:29 am
nuvb
Nuvation Bio (NYSE:NUVB) had its price target lowered by analysts at HC Wainwright from $18.00 to $17.00. They now have a "buy" rating on the stock.
High
Report
Nuvation Bio (NYSE:NUVB) had its price target lowered by analysts at HC Wainwright from $18.00 to $17.00. They now have a "buy" rating on the stock.
1/12
08:55 am
nuvb
Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
High
Report
Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/12
08:44 am
nuvb
Nuvation Bio says preliminary Q4 and FY25 IBTROZI net product revenue was $15.7M and $24.7M [Seeking Alpha]
High
Report
Nuvation Bio says preliminary Q4 and FY25 IBTROZI net product revenue was $15.7M and $24.7M [Seeking Alpha]
1/12
08:00 am
nuvb
Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference
High
Report
Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference
1/12
07:30 am
nuvb
Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan
High
Report
Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan
1/9
06:10 am
nuvb
Nuvation Bio (NYSE:NUVB) was upgraded by analysts at UBS Group AG to a "hold" rating.
Medium
Report
Nuvation Bio (NYSE:NUVB) was upgraded by analysts at UBS Group AG to a "hold" rating.
Date
Time
Symbol
Company Name
Action
%Chg
11/3/2025
04:05 pm
NUVB
nuvation bio inc. class a
BEAT
Report
-6.6%
nuvation bio inc. class a
8/7/2025
07:30 am
NUVB
nuvation bio inc. class a
IN-LINE
Report
-3.7%
nuvation bio inc. class a
5/7/2025
04:05 pm
NUVB
nuvation bio inc. class a
IN-LINE
Report
2.9%
nuvation bio inc. class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/12
08:07 am
nuvb
Form 8-K Nuvation Bio Inc. For: Jan 11
High
Report
Form 8-K Nuvation Bio Inc. For: Jan 11
12/3
05:02 pm
nuvb
Form 4 Nuvation Bio Inc. For: Dec 01 Filed by: Liu Dongfang
Low
Report
Form 4 Nuvation Bio Inc. For: Dec 01 Filed by: Liu Dongfang
12/1
04:51 pm
nuvb
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
Medium
Report
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
11/26
05:55 pm
nuvb
Form 4 Nuvation Bio Inc. For: Nov 25 Filed by: Liu Dongfang
Low
Report
Form 4 Nuvation Bio Inc. For: Nov 25 Filed by: Liu Dongfang
11/26
04:34 pm
nuvb
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
Low
Report
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
11/26
08:34 am
nuvb
Form 8-K Nuvation Bio Inc. For: Nov 26
Low
Report
Form 8-K Nuvation Bio Inc. For: Nov 26
11/25
04:23 pm
nuvb
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
Low
Report
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
11/24
04:10 pm
nuvb
Form 4 Nuvation Bio Inc. For: Nov 20 Filed by: Hattersley Gary
Medium
Report
Form 4 Nuvation Bio Inc. For: Nov 20 Filed by: Hattersley Gary
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: